2025 United Kingdom Antimicrobial Susceptibility Testing Market Revenue Opportunities Report
Description
The 2025 United Kingdom Antimicrobial Susceptibility Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the United Kingdom's Antimicrobial Susceptibility Testing (AST) market include Thermo Fisher Scientific Inc., bioMérieux S.A., Danaher Corporation, and Bio-Rad Laboratories, Inc. Thermo Fisher offers advanced diagnostic technologies such as the Sensititre and MAS systems, facilitating rapid and precise susceptibility profiles essential for clinical decisions. bioMérieux is recognized for its innovative AST solutions that enhance detection and management of antimicrobial resistance. Danaher, through subsidiaries like Beckman Coulter, provides systems like DxN VERIS and MicroScan, supporting fast and comprehensive testing. Bio-Rad contributes through products like the MRSA-Screen and VITEK 2 Systems that help laboratories swiftly identify resistant strains.
These companies maintain significant market presence in the UK and globally through product innovation and collaborations, addressing rising antimicrobial resistance challenges. The UK market, valued at USD 165 million in 2023, is expected to grow substantially, driven by increased antibiotic resistance and government initiatives to improve antimicrobial stewardship. AST technologies from these firms support appropriate therapy selection, contributing to healthcare efficiency and better patient outcomes in the UK.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the United Kingdom's Antimicrobial Susceptibility Testing (AST) market include Thermo Fisher Scientific Inc., bioMérieux S.A., Danaher Corporation, and Bio-Rad Laboratories, Inc. Thermo Fisher offers advanced diagnostic technologies such as the Sensititre and MAS systems, facilitating rapid and precise susceptibility profiles essential for clinical decisions. bioMérieux is recognized for its innovative AST solutions that enhance detection and management of antimicrobial resistance. Danaher, through subsidiaries like Beckman Coulter, provides systems like DxN VERIS and MicroScan, supporting fast and comprehensive testing. Bio-Rad contributes through products like the MRSA-Screen and VITEK 2 Systems that help laboratories swiftly identify resistant strains.
These companies maintain significant market presence in the UK and globally through product innovation and collaborations, addressing rising antimicrobial resistance challenges. The UK market, valued at USD 165 million in 2023, is expected to grow substantially, driven by increased antibiotic resistance and government initiatives to improve antimicrobial stewardship. AST technologies from these firms support appropriate therapy selection, contributing to healthcare efficiency and better patient outcomes in the UK.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
